G. Merrick

W. Butler, G. Merrick, 2016, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Appropriate Exercise Training Benefits Men Receiving Androgen Deprivation Therapy

W. Butler, G. Merrick, R. Galbreath, 2006 .

Prostate brachytherapy biochemical relapse-free survival outcomes in intermediate-risk prostate cancer patients

J. Sylvester, P. Grimm, G. Merrick, 2009 .

Analysis of the Pro-qura Database: Implant Quality, Brachytherapist Experience and Rectal Dose Parameters

J. Sylvester, P. Grimm, W. Butler, 2008 .

Nursing considerations in brachytherapy-related erectile dysfunction.

K. Wallner, W. Butler, G. Merrick, 2005, Urologic nursing.

Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy

W. Butler, G. Merrick, R. Galbreath, 2017, American journal of clinical oncology.

Prognostic importance of tobacco use in men receiving definitive prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2012, Brachytherapy.

Comment on the "AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137" [Med. Phys. 36, 5310-5322 (2009)].

J. Blasko, G. Merrick, 2009, Medical physics.

Factors affecting patient selection for prostate brachytherapy: what nurses should know.

K. Wallner, W. Butler, G. Merrick, 2005, Clinical journal of oncology nursing.

ACR Appropriateness Criteria (cid:1) Postradical Prostatectomy Irradiation in Prostate Cancer

G. Merrick, B. Moran, N. Hahn, 2011 .

The Impact of Diabetes Mellitus on Survival in Men With Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2010, American journal of clinical oncology.

The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2007, Brachytherapy.

Selecting patients with pretreatment postvoid residual urine volume less than 100 mL may favorably influence brachytherapy-related urinary morbidity.

K. Wallner, W. Butler, G. Merrick, 2005, Urology.

The Wheeling approach to treatment planning for prostate brachytherapy

W. Butler, G. Merrick, 2005 .

The effect of constipation on rectal dosimetry following prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.

W. Butler, G. Merrick, R. Galbreath, 2013, The Journal of urology.

Isodose patterns in patients with inadequate prostate brachytherapy coverage.

K. Wallner, S. Sutlief, W. Butler, 2003, International journal of radiation oncology, biology, physics.

American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer.

G. Merrick, J. Ciezki, J. Mohler, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

LOCALLY ADVANCED, HIGH-RISK PROSTATE CANCER

Y. Yamada, G. Merrick, J. Ciezki, 2016 .

Role of trospium chloride in brachytherapy-related detrusor overactivity.

K. Wallner, W. Butler, G. Merrick, 2008, Urology.

Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer.

K. Wallner, W. Butler, G. Merrick, 2006, International journal of radiation oncology, biology, physics.

Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy

K. Wallner, W. Butler, G. Merrick, 2006, BJU international.

Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2005, Urology.

Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2004, International journal of radiation oncology, biology, physics.

High-dose regions versus likelihood of cure after prostate brachytherapy.

K. Wallner, S. Sutlief, W. Butler, 2005, International journal of radiation oncology, biology, physics.

Iodine-125 vs palladium-103 for low-risk prostate cancer: Preliminary urinary functional outcomes from a prospective randomized multicenter trial

W. Cavanagh, K. Wallner, M. Kattan, 2000 .

The narrow door of success.

G. Merrick, 2019, Brachytherapy.

There Is a Wide Range of Predictive Dosimetric Factors for I-125 and Pd-103 Prostate Brachytherapy

K. Wallner, S. Sutlief, W. Butler, 2008, American journal of clinical oncology.

Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.

K. Wallner, S. Sutlief, W. Butler, 2007, International journal of radiation oncology, biology, physics.

In response to Dr. Rubenstein

K. Wallner, G. Merrick, Daniel Reed, 2005 .

Potential role of various dosimetric quality indicators in prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 1999, International journal of radiation oncology, biology, physics.

Transperineal Template-guided Mapping Biopsy as a Staging Procedure to Select Patients Best Suited for Active Surveillance

W. Butler, G. Merrick, R. Galbreath, 2013, American journal of clinical oncology.

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts

W. Butler, G. Merrick, R. Galbreath, 2015, Journal of contemporary brachytherapy.

Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy

W. Butler, G. Merrick, R. Galbreath, 2016, American journal of clinical oncology.

Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials

K. Wallner, W. Butler, G. Merrick, 2017, Journal of contemporary brachytherapy.

Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.

K. Wallner, W. Butler, G. Merrick, 2006, European urology.

Extracapsular Radiation Dose Distribution After Permanent Prostate Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2003, American journal of clinical oncology.

American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.

Wayne M Butler, Louis Potters, Anthony L Zietman, 2012, Brachytherapy.

DEFINITIVE EXTERNAL-BEAM IRRADIATION IN STAGE T1 AND T2 PROSTATE CANCER

A. D'Amico, Y. Yamada, G. Gustafson, 2013 .

Appropriateness Criteria s Definitive External Beam Irradiation in Stage T 1 and T 2 Prostate Cancer

Y. Yamada, G. Merrick, J. Ciezki, 2014 .

ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer

Y. Yamada, G. Merrick, J. Ciezki, 2011, American journal of clinical oncology.

Interstitial brachytherapy should be standard of care for treatment of high-risk prostate cancer.

K. Wallner, W. Butler, G. Merrick, 2008, Oncology.

Prognostic Significance of Percent Positive Biopsies in Clinically Organ Confined Prostate Cancer Treated with Permanent Prostate Brachytherapy With or Without Supplemental External Beam Radiation

K. Wallner, W. Butler, G. Merrick, 2004, Cancer journal.

Reviving the acid phosphatase test for prostate cancer.

Kent Wallner, K. Wallner, G. Merrick, 2007, Oncology.

Myths and fallacies in permanent prostate brachytherapy.

W. Butler, G. Merrick, 2003, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

A. Kishan, B. Trock, P. Boutros, 2021, JAMA network open.

American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.

Mark J Rivard, Wayne M Butler, Ali S Meigooni, 2007, Brachytherapy.

Effect of post-implant edema on prostate brachytherapy treatment margins.

K. Wallner, S. Sutlief, W. Butler, 2005, International journal of radiation oncology, biology, physics.

Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy

W. Butler, G. Merrick, R. Galbreath, 2014, Journal of contemporary brachytherapy.

Short‐term sexual function after prostate brachytherapy

K. Wallner, S. Sutlief, W. Butler, 2001, International journal of cancer.

American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer.

J. Blasko, M. Zelefsky, G. Merrick, 2017, Brachytherapy.

Morbidity after brachytherapy for prostate adenocarcinoma.

K. Wallner, W. Butler, G. Merrick, 2004, Mayo Clinic proceedings.

The Impact of Primary Gleason Grade on Biochemical Outcome Following Brachytherapy for Hormone‐Naive Gleason Score 7 Prostate Cancer

K. Wallner, W. Butler, G. Merrick, 2005, Cancer journal.

ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance.

G. Merrick, A. Oto, S. Eberhardt, 2013, Journal of the American College of Radiology : JACR.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, P. McLaughlin, D. Hamstra, 2016, American journal of clinical oncology.

Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.

K. Wallner, W. Butler, G. Merrick, 2008, Brachytherapy.

Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland.

K. Wallner, W. Butler, G. Merrick, 2003, The Journal of urology.

The morbidity of transperineal template‐guided prostate mapping biopsy

K. Wallner, W. Butler, G. Merrick, 2008, BJU international.

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

K. Wallner, W. Butler, G. Merrick, 2009, Prostate Cancer and Prostatic Diseases.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

A. Kishan, A. D'Amico, D. Song, 2018, JAMA.

Prostate brachytherapy in men > or =75 years of age.

K. Wallner, W. Butler, G. Merrick, 2008, International journal of radiation oncology, biology, physics.

Primary causes of death after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2008, International journal of radiation oncology, biology, physics.

Penile Rehabilitative Therapy after Brachytherapy for Early Stage Prostate Cancer

W. Butler, G. Merrick, R. Galbreath, 2007 .

Brachytherapy-associated erectile dysfunction

K. Wallner, W. Butler, G. Merrick, 2005 .

Management of sexual dysfunction after prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2003, Oncology.

Nursing assessment of sexual function following permanent prostate brachytherapy for patients with early-stage prostate cancer.

W. Butler, G. Merrick, J. Lief, 2002, Clinical journal of oncology nursing.

Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2005, International journal of radiation oncology, biology, physics.

15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience.

Robert W Galbreath, Jeremy Millar, J. Blasko, 2007, International journal of radiation oncology, biology, physics.

Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?

J. Blasko, K. Wallner, W. Butler, 2006, Oncology.

Prostate 15-YEAR BIOCHEMICAL RELAPSE FREE SURVIVAL IN CLINICAL STAGE T 1T 3 PROSTATE CANCER FOLLOWING COMBINED EXTERNAL BEAM RADIOTHERAPY AND BRACHYTHERAPY ; SEATTLE EXPERIENCE

J. Blasko, J. Sylvester, P. Grimm, 2006 .

Epididymitis after prostate brachytherapy.

K. Wallner, G. Merrick, S. Hoffelt, 2004, Urology.

Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.

W. Butler, G. Merrick, Z. Allen, 2004, Urology.

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.

Todd McNutt, Ahmad Sadeghi, Patrick A Kupelian, 2017, International journal of radiation oncology, biology, physics.

Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization

G. Merrick, P. McLaughlin, R. Dess, 2019, American journal of clinical oncology.

American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy.

K. Wallner, G. Merrick, S. Nag, 2002, International journal of radiation oncology, biology, physics.

High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2011, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Brachytherapy.

Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.

J. Blasko, J. Sylvester, P. Grimm, 2007, Brachytherapy.

Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience.

J. Blasko, J. Sylvester, P. Grimm, 2011, International journal of radiation oncology, biology, physics.

Long-term urinary quality of life after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2003, International journal of radiation oncology, biology, physics.

The Incidence of Transition Zone Prostate Cancer Diagnosed by Transperineal Template Guided Mapping Biopsy: Implications for Treatment Planning

K. Wallner, W. Butler, G. Merrick, 2010 .

Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Adam P Dicker, Richard Stock, Steven Frank, 2012, BJU international.

Seed fixity in the prostate/periprostatic region following brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, International journal of radiation oncology, biology, physics.

The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.

K. Wallner, W. Butler, G. Merrick, 2002, International journal of radiation oncology, biology, physics.

Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very–Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance

W. Butler, G. Merrick, E. Adamovich, 2017, American journal of clinical oncology.

American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review.

P. Grimm, M. Zelefsky, G. Merrick, 2017, Brachytherapy.

Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?

K. Wallner, G. Merrick, L. Fang, 2010, Oncology.

The dosimetry of prostate brachytherapy-induced urethral strictures.

W. Butler, G. Merrick, J. Lief, 2001, International journal of radiation oncology, biology, physics.

ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Oncology.

Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.

K. Wallner, W. Butler, G. Merrick, 2011, Urologic oncology.

American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.

Y. Yamada, G. Merrick, J. Ciezki, 2011, Brachytherapy.

Brachytherapy‐related dysuria

K. Wallner, W. Butler, G. Merrick, 2005, BJU international.

The impact of radiation dose to the urethra on brachytherapy-related dysuria.

K. Wallner, W. Butler, G. Merrick, 2005, Brachytherapy.

Dysuria after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2003, International journal of radiation oncology, biology, physics.

I‐125 Versus Pd‐103 for Low‐Risk Prostate Cancer: Long‐Term Morbidity Outcomes From a Prospective Randomized Multicenter Controlled Trial

W. Cavanagh, K. Wallner, W. Butler, 2005, Cancer journal.

Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2004, International journal of radiation oncology, biology, physics.

A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.

W. Butler, G. Merrick, A. T. Dorsey, 2000, International journal of radiation oncology, biology, physics.

Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction.

W. Butler, G. Merrick, A. T. Dorsey, 1999, Urology.

Radiotherapy versus radical prostatectomy for Gleason score 9-10 prostate adenocarcinoma: A multi-institutional comparative analysis of 1001 patients treated in the modern era.

A. Kishan, G. Merrick, J. Ciezki, 2017 .

Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.

Wayne M Butler, Robert W Galbreath, K. Wallner, 2005, The West Virginia medical journal.

Severe rectal complications after prostate brachytherapy.

K. Wallner, S. Sutlief, G. Merrick, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Severe rectal complications after prostate brachytherapy q

K. Wallner, S. Sutlief, G. Merrick, 2015 .

Rapid strand™ vs. loose (iodine-125 seeds): A prospective randomized trial

K. Wallner, G. Merrick, E. Ford, 2004 .

125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial.

W. Cavanagh, K. Wallner, S. Sutlief, 2003, International journal of radiation oncology, biology, physics.

Permanent prostate brachytherapy for high-risk prostate cancer

K. Wallner, W. Butler, G. Merrick, 2007 .

Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.

K. Wallner, W. Butler, G. Merrick, 2005, International journal of radiation oncology, biology, physics.

Patient selection for prostate brachytherapy: more myth than fact.

K. Wallner, W. Butler, G. Merrick, 2004, Oncology.

Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy.

K. Wallner, G. Merrick, L. True, 2003, Urology.

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2002, Urology.

Prostate-specific antigen spikes after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2002, International journal of radiation oncology, biology, physics.

Comparison of seed loading approaches in prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, Medical physics.

Rectal dosimetric analysis following prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 1999, International journal of radiation oncology, biology, physics.

Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2004, International journal of radiation oncology, biology, physics.

Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy.

Daniel A Hamstra, G. Merrick, P. McLaughlin, 2013, International journal of radiation oncology, biology, physics.

The addition of low‐dose‐rate brachytherapy and androgen‐deprivation therapy decreases biochemical failure and prostate cancer death compared with dose‐escalated external‐beam radiation therapy for high‐risk prostate cancer

G. Merrick, H. Sandler, P. McLaughlin, 2013, Cancer.

Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer

W. Butler, G. Merrick, J. Lief, 2007, Cancer.

Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2006, Urology.

Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.

L. Potters, M. Zelefsky, W. Butler, 2021, Brachytherapy.

Prostate cancer death is unlikely in high‐risk patients following quality permanent interstitial brachytherapy

K. Wallner, W. Butler, G. Merrick, 2011, BJU international.

Erectile function after prostate brachytherapy.

Wayne M Butler, Robert W Galbreath, K. Wallner, 2005, International journal of radiation oncology, biology, physics.

Erectile function after permanent prostate brachytherapy.

W. Butler, G. Merrick, J. Lief, 2002, International journal of radiation oncology, biology, physics.

A biochemical definition of cure after brachytherapy for prostate cancer.

G. Merrick, W. J. Morris, J. Ciezki, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer

A. Kishan, P. Boutros, D. Song, 2022, JAMA oncology.

Penile bulb imaging.

K. Wallner, W. Butler, G. Merrick, 2002, International journal of radiation oncology, biology, physics.

Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2006, International journal of radiation oncology, biology, physics.

Temporal resolution of urinary morbidity following prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, International journal of radiation oncology, biology, physics.

The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer.

G. Merrick, B. Prestidge, P. Orio, 2017, Brachytherapy.

Permanent prostate brachytherapy in prostate glands <20 cm(3).

K. Wallner, W. Butler, G. Merrick, 2010, International journal of radiation oncology, biology, physics.

Erectile function durability following permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2009, International journal of radiation oncology, biology, physics.

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.

A. Kishan, A. D'Amico, D. Song, 2020, European urology.

Dosimetry of an Extracapsular Anulus Following Permanent Prostate Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2007, American journal of clinical oncology.

Extraprostatic Seed Placement and Its Effect on Seed Loss

K. Wallner, S. Sutlief, G. Merrick, 2005, Cancer journal.

Greater biopsy core number is associated with improved biochemical control in patients treated with permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2010, International journal of radiation oncology, biology, physics.

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2003, Brachytherapy.

Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.

W. Butler, G. Merrick, A. T. Dorsey, 1997, Radiation oncology investigations.

Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy

J. Sylvester, W. Butler, G. Merrick, 2009, American journal of clinical oncology.

Radioactive seed embolization to the lung following prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, West Virginia Medical Journal.

Response to Drs Rogers, Hayes, and Demanes.

A. D'Amico, Y. Yamada, G. Gustafson, 2014, Brachytherapy.

Prostate cryotherapy: more questions than answers.

K. Wallner, W. Butler, G. Merrick, 2005, Urology.

Permanent Interstitial Brachytherapy for Clinically Organ-Confined High-Grade Prostate Cancer With a Pretreatment PSA < 20 ng/mL

K. Wallner, W. Butler, G. Merrick, 2004, American journal of clinical oncology.

Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high‐risk prostate cancer?

W. Butler, G. Merrick, J. Lief, 2003, BJU international.

Biochemical Outcome for Hormone‐Naïve Patients with High‐Risk Prostate Cancer Managed with Permanent Interstitial Br achy therapy and Supplemental External‐Beam Radiation

W. Butler, G. Merrick, J. Lief, 2002, Cancer journal.

Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy.

K. Wallner, W. Butler, G. Merrick, 2011, International journal of radiation oncology, biology, physics.

Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2007, International journal of radiation oncology, biology, physics.

The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2006, International journal of radiation oncology, biology, physics.

PSA spike after brachytherapy For localized prostate cancer.

K. Wallner, G. Merrick, Sarah G. Brammer, 2007, Urologic nursing.

ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.

P. Carroll, G. Merrick, D. Beyer, 2009, International journal of radiation oncology, biology, physics.

Chronic pelvic pain following prostate brachytherapy: a case report.

K. Wallner, G. Merrick, M. Ghaly, 2004, Brachytherapy.

In response to Dr. Lee

K. Wallner, G. Merrick, M. Ghaly, 2003 .

Minimizing prostate brachytherapy-related morbidity.

K. Wallner, W. Butler, G. Merrick, 2003, Urology.

Medical malpractice of prostate brachytherapy.

K. Wallner, G. Merrick, K. Elliott, 2004, Brachytherapy.

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.

A. Kishan, P. Boutros, D. Song, 2021, European urology.

Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.

W. Butler, G. Merrick, J. Lief, 2001, International journal of radiation oncology, biology, physics.

Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community database.

P. Grimm, W. Butler, G. Merrick, 2013, Brachytherapy.

Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.

W. Butler, G. Merrick, A. T. Dorsey, 2000, Techniques in urology.

20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trial.

K. Wallner, W. Butler, G. Merrick, 2012, International journal of radiation oncology, biology, physics.

The Time Gap Between Pd-103 Prostate Brachytherapy and Supplemental Beam Radiation Does Not Impact on Rectal Morbidity or Likelihood of Cure

K. Wallner, G. Merrick, L. True, 2007, American journal of clinical oncology.

Rectal function following permanent prostate brachytherapy.

W. Butler, G. Merrick, 2004, The West Virginia medical journal.

The dosimetry of brachytherapy-induced erectile dysfunction.

W. Butler, G. Merrick, 2003, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for 103palladium brachytherapy

Ravinder Nath, Colin G. Orton, J. Blasko, 2000 .

The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetry.

K. Wallner, W. Butler, G. Merrick, 2011, Brachytherapy.

Radiation thresholds and rehabilitative therapy with erectile preservation after radiotherapy for prostate cancer

K. Wallner, W. Butler, G. Merrick, 2007 .

Risk factors for the development of prostate brachytherapy related urethral strictures.

K. Wallner, W. Butler, G. Merrick, 2006, The Journal of urology.

Erectile Function After Prostate Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2006 .

Potency-Sparing Radiation: Myth or Reality?

G. Merrick, P. McLaughlin, 2009 .

Extracapsular radiation dose distribution following permanent prostate brachytherapy

K. Wallner, W. Butler, G. Merrick, 2001 .

Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation.

W. Butler, G. Merrick, 2000, Techniques in urology.

Comparison of MRI pulse sequences in defining prostate volume after permanent implantation: in regard to McLaughlin et al., IJROBP 2002;54:703-711.

K. Wallner, W. Butler, G. Merrick, 2003, International journal of radiation oncology, biology, physics.

Treatment outcomes and quality-of-life issues for patients treated with prostate brachytherapy.

W. Butler, G. Merrick, L. Abel, 2003, Clinical journal of oncology nursing.

American brachytherapy society recommendations for clinical implementation of nist-1999 standards for palladium-103 brachytherapy. Authors' reply

J. Blasko, B. Vikram, W. Butler, 2001 .

Effects of the Time Interval Between Prostate Brachytherapy and Postimplant Dosimetric Evaluation in Community Practice: Analysis of the Pro-Qura Database

J. Blasko, J. Sylvester, P. Grimm, 2008, American journal of clinical oncology.

Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional database.

J. Blasko, J. Sylvester, P. Grimm, 2008, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Commentary on "Medical malpractice in the age of technology: how specialty societies can make a difference (Anscher and Anscher)".

K. Wallner, G. Merrick, K. Elliott, 2006, Brachytherapy.

Gross hematuria after prostate brachytherapy.

K. Wallner, G. Merrick, J. Barker, 2003, Urology.

Modification of prostate implants based on postimplant treatment margin assessment.

K. Wallner, S. Sutlief, W. Butler, 2002, Medical physics.

In response to Drs. Vikram, Anderson, and King

J. Blasko, W. Butler, G. Merrick, 2001 .

Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, International journal of radiation oncology, biology, physics.

Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 1998, Radiation oncology investigations.

Multisector prostate dosimetric quality: analysis of a large community database.

P. Grimm, W. Butler, G. Merrick, 2014, Brachytherapy.

Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA

W. Butler, G. Merrick, R. Galbreath, 2017, Journal of contemporary brachytherapy.

Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.

J. Sylvester, P. Grimm, W. Butler, 2009, Brachytherapy.

Analysis of the Pro-Qura Database: rectal dose, implant quality, and brachytherapist's experience.

J. Sylvester, P. Grimm, W. Butler, 2009, Brachytherapy.

1–125 Versus Pd‐103 for Low‐Risk Prostate Cancer: Morbidity Outcomes from a Prospective Randomized Multicenter Trial

W. Cavanagh, K. Wallner, W. Butler, 2002, Cancer journal.

Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy.

W. Butler, G. Merrick, J. Lief, 2001, Urology.

Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking.

Wayne M Butler, Nathan Bittner, W. Butler, 2015, Practical radiation oncology.

ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer.

G. Merrick, J. Ciezki, S. Rosenthal, 2011, American journal of clinical oncology.

20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial.

W. Cavanagh, K. Wallner, S. Sutlief, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials.

W. Cavanagh, K. Wallner, S. Sutlief, 2003, International journal of radiation oncology, biology, physics.

Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.

W. Cavanagh, K. Wallner, S. Sutlief, 2004, Brachytherapy.

20 Gy Versus 44 Gy Supplemental Beam Radiation with Pd-103 Prostate Brachytherapy: Early Biochemical Outcomes From a Prospective Randomized Multi-Center Trial

K. Wallner, S. Sutlief, W. Butler, 2005 .

Late rectal function after prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2003, International journal of radiation oncology, biology, physics.

Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.

W. Cavanagh, K. Wallner, S. Sutlief, 2003, Brachytherapy.

The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients

W. Butler, G. Merrick, E. Adamovich, 2021, American journal of clinical oncology.

The Impact of Diabetes Mellitus on Survival in Men With Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2012, American journal of clinical oncology.

ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer.

G. Merrick, J. Ciezki, S. Rosenthal, 2011, American journal of clinical oncology.

ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer

G. Merrick, J. Ciezki, S. Rosenthal, 2011, American journal of clinical oncology.

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer

A. D'Amico, Y. Yamada, G. Gustafson, 2011, American journal of clinical oncology.

Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapy

K. Wallner, W. Butler, G. Merrick, 2010, BJU international.

Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy.

K. Wallner, W. Butler, G. Merrick, 2013, Brachytherapy.

Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2008, International journal of radiation oncology, biology, physics.

Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy

G. Merrick, D. Hamstra, J. Vainshtein, 2016, American journal of clinical oncology.

The impact of age on prostate cancer progression and quality of life in active surveillance patients

W. Butler, G. Merrick, E. Adamovich, 2020, BJUI compass.

Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection

W. Butler, G. Merrick, R. Galbreath, 2019, World Journal of Urology.

Intrafraction displacement of prone versus supine prostate positioning monitored by real‐time electromagnetic tracking

W. Butler, G. Merrick, B. Kurko, 2013, Journal of applied clinical medical physics.

American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.

Y. Yamada, G. Merrick, J. Mohler, 2011, Brachytherapy.

Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.

J. Blasko, P. Grimm, K. Wallner, 2005, Brachytherapy.

Pathology and Quality of Life Outcomes Following Office-based Transperineal Prostate Biopsy.

W. Butler, G. Merrick, E. Adamovich, 2016, Urology.

High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2011, International journal of radiation oncology, biology, physics.

Permanent prostate brachytherapy in prostate glands <20 cm(3).

K. Wallner, W. Butler, G. Merrick, 2010, International journal of radiation oncology, biology, physics.

Clinical practice and quality assurance challenges in modern brachytherapy sources and dosimetry.

W. Butler, G. Merrick, 2008, International journal of radiation oncology, biology, physics.

Long-Term Rectal Function After Permanent Prostate Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2007, Cancer journal.

The Impact of Prostate Volume and Neoadjuvant Androgen‐Deprivation Therapy on Urinary Function Following Prostate Brachytherapy

K. Wallner, W. Butler, G. Merrick, 2004, Cancer journal.

Five-year biochemical outcome after prostate brachytherapy for hormone-naive men < or = 62 years of age.

W. Butler, G. Merrick, J. Lief, 2001, International journal of radiation oncology, biology, physics.

Rectal function following prostate brachytherapy.

W. Butler, G. Merrick, A. T. Dorsey, 2000, International journal of radiation oncology, biology, physics.

Isotope choice and the effect of edema on prostate brachytherapy dosimetry.

W. Butler, G. Merrick, A. T. Dorsey, 2000, Medical physics.

The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.

K. Wallner, W. Butler, G. Merrick, 2004, Brachytherapy.

Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation.

W. Butler, G. Merrick, J. Lief, 2002, Brachytherapy.